Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Goal Achievement of A1c and LDL in a Randomized Trial Comparing Colesevelam vs. Ezetimibe as Add-on to Baseline Statin Therapy: The GOAL-RCT Trial

NCT02682680 is registered in ClinicalTrials.gov with LMC Diabetes & Endocrinology Ltd. as lead sponsor.

NCT NCT02682680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02682680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Goal Achievement of A1c and LDL in a Randomized Trial Comparing Colesevelam vs. Ezetimibe as Add-on to Baseline Statin Therapy: The GOAL-RCT Trial
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Phase
Phase 4
Overall status
Completed
Start date
January 11, 2016
Completion date
May 25, 2017
Enrollment
200 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus